PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma

The dependence of cancer on an immunotolerant tumor microenvironment (TME) is well established. Immunotherapies that overcome tumor-induced immune suppression have been central to recent advancements in oncology. This is highlighted by the success of agents that interrupt PD-1 mediated immune suppre...

詳細記述

書誌詳細

出版年:	Cells
主要な著者:	Joshua W. D. Tobin, Karolina Bednarska, Ashlea Campbell, Colm Keane
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2021-05-01
主題:	immune checkpoint blockade PD-1 LAG-3 Hodgkin lymphoma non-Hodgkin lymphoma follicular lymphoma
オンライン･アクセス:	https://www.mdpi.com/2073-4409/10/5/1152